- Location
tyrosine kinases
"-
Loxo Oncology Acquired Rights to This Program From Array Biopharma
Oct 30, 2013US-based Loxo Oncology has announced that its lead clinical program is a potent and selective inhibitor of the Trk family of receptor tyrosine kinases. Loxo Oncology acquired rights to this program from Array Biopharma, which had pursued ...
Tags: Loxo Oncology, Medicine
-
Exelixis Has Announced The Availability of Cometriq (Cabozantinib)
Jan 29, 2013Exelixis has announced the availability of Cometriq (cabozantinib), indicated for medullary thyroid cancer (MTC), in the US. Diplomat Specialty Pharmacy is distributing the product across the US. Cometriq that is developed to inhibit ...
Tags: Exelixis, Cometriq, tyrosine kinases
-
The European Commission Will Review CHMP's Positive Opinion
Dec 4, 2012Pfizer has received positive opinion from the Committee for Human Medicinal Products (CHMP) of the European Medicines Agency for the marketing authorization of axitinib to treat patients with advanced renal cell carcinoma. The European ...
Related Products
-
a Tyrosine Kinase Receptor (MERTK) Inhibitor 1197953-54-0 Brigatinib
-
L-Arginine Various Amino Acid Feed Additives Food Grade Feed Grade L-Arginine
-
99% L-Arginine Food Grade Nutritional Fortifier (CAS: 74-79-3)
-
L Arginine Edible Amino Acid Powder Food Fortification Supplement (CAS: 74-79-3)
-
Wholesale Price of High-Quality Amino Acid L-Arginine Feed Grade Factory CAS: 74-79-3
-
L-Arginine Food Grade Amino Acid Nutritional Fortifier Content 99% (CAS: 74-79-3)
